Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery

J Antimicrob Chemother. 1999 Aug;44(2):287-90. doi: 10.1093/jac/44.2.287.

Abstract

The efficacy of antibiotic prophylaxis in cardiac surgery was compared between 97 patients receiving a single 2 g dosage of ceftriaxone and 103 receiving 500 mg of vancomycin i.v. every 6 h for 48 h. The overall infection rate was 13.4% in the ceftriaxone and 10.7% in the vancomycin group. Four (4%) wound infections, including one mediastinitis, occurred in the ceftriaxone group and five (5%) in the vancomycin group, with no statistically significant difference. The findings of this study support the adequacy of a simple single dose of ceftriaxone prophylaxis in cardiac surgery, at least in hospitals with low incidence of vancomycin-resistant staphylococcal infections.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Antibiotic Prophylaxis*
  • Bacterial Infections / prevention & control
  • Ceftriaxone / therapeutic use*
  • Cephalosporins / therapeutic use*
  • Coronary Artery Bypass*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Surgical Wound Infection / prevention & control*
  • Vancomycin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Vancomycin
  • Ceftriaxone